These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing. Swerdlow SH; Kuzu I; Dogan A; Dirnhofer S; Chan JK; Sander B; Ott G; Xerri L; Quintanilla-Martinez L; Campo E Virchows Arch; 2016 Mar; 468(3):259-75. PubMed ID: 26454445 [TBL] [Abstract][Full Text] [Related]
3. MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma. Martinez-Lopez A; Curiel-Olmo S; Mollejo M; Cereceda L; Martinez N; Montes-Moreno S; Almaraz C; Revert JB; Piris MA Am J Surg Pathol; 2015 May; 39(5):644-51. PubMed ID: 25723115 [TBL] [Abstract][Full Text] [Related]
4. Myeloid nuclear differentiation antigen: an aid in differentiating lymphoplasmacytic lymphoma and splenic marginal zone lymphoma in bone marrow biopsies at presentation. Righi S; Novero D; Godio L; Bertuzzi C; Bacci F; Agostinelli C; Sagramoso C; Rossi M; Piccioli M; Gazzola A; Mannu C; Roncador G; Sabattini E Hum Pathol; 2022 Jun; 124():67-75. PubMed ID: 35339566 [TBL] [Abstract][Full Text] [Related]
5. Aggressive Lymphoplasmacytic Neoplasm With an Unusual In-frame Deletion of Yan M; Meyerson H; Oduro KA; Shetty S; Yoest J Int J Surg Pathol; 2024 Feb; 32(1):5-10. PubMed ID: 37093763 [TBL] [Abstract][Full Text] [Related]
6. An unusual case of cutaneous Waldenström macroglobulinemia with the MYD88 L265P mutation. Minzenmayer AN; Miranda RN; Powell PR; Parekh PK J Cutan Pathol; 2020 Sep; 47(9):850-853. PubMed ID: 32335928 [TBL] [Abstract][Full Text] [Related]
7. MYD88 L265P somatic mutation: its usefulness in the differential diagnosis of bone marrow involvement by B-cell lymphoproliferative disorders. Ondrejka SL; Lin JJ; Warden DW; Durkin L; Cook JR; Hsi ED Am J Clin Pathol; 2013 Sep; 140(3):387-94. PubMed ID: 23955458 [TBL] [Abstract][Full Text] [Related]
8. Lymphoplasmacytic lymphoma and marginal zone lymphoma in the bone marrow: paratrabecular involvement as an important distinguishing feature. Bassarova A; Trøen G; Spetalen S; Micci F; Tierens A; Delabie J Am J Clin Pathol; 2015 Jun; 143(6):797-806. PubMed ID: 25972321 [TBL] [Abstract][Full Text] [Related]
9. Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease. Cao XX; Meng Q; Cai H; He TH; Zhang CL; Su W; Sun J; Li Y; Xu W; Zhou DB; Li J Ann Hematol; 2017 Jun; 96(6):971-976. PubMed ID: 28280994 [TBL] [Abstract][Full Text] [Related]
10. IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas. Gachard N; Parrens M; Soubeyran I; Petit B; Marfak A; Rizzo D; Devesa M; Delage-Corre M; Coste V; Laforêt MP; de Mascarel A; Merlio JP; Bouabdhalla K; Milpied N; Soubeyran P; Schmitt A; Bordessoule D; Cogné M; Feuillard J Leukemia; 2013 Jan; 27(1):183-9. PubMed ID: 22944768 [TBL] [Abstract][Full Text] [Related]
11. Lymphoplasmacytic Lymphoma With a Non-IgM Paraprotein Shows Clinical and Pathologic Heterogeneity and May Harbor MYD88 L265P Mutations. King RL; Gonsalves WI; Ansell SM; Greipp PT; Frederick LA; Viswanatha DS; He R; Kyle RA; Gertz MA; Kapoor P; Morice WG; Howard MT Am J Clin Pathol; 2016 Jun; 145(6):843-51. PubMed ID: 27329639 [TBL] [Abstract][Full Text] [Related]
12. Significance of MYD88 L265P Mutation Status in the Subclassification of Low-Grade B-Cell Lymphoma/Leukemia. Insuasti-Beltran G; Gale JM; Wilson CS; Foucar K; Czuchlewski DR Arch Pathol Lab Med; 2015 Aug; 139(8):1035-41. PubMed ID: 26230596 [TBL] [Abstract][Full Text] [Related]
13. MYD88 L265P and CXCR4 mutations in lymphoplasmacytic lymphoma identify cases with high disease activity. Schmidt J; Federmann B; Schindler N; Steinhilber J; Bonzheim I; Fend F; Quintanilla-Martinez L Br J Haematol; 2015 Jun; 169(6):795-803. PubMed ID: 25819228 [TBL] [Abstract][Full Text] [Related]
15. A novel diagnostic approach for the classification of small B-cell lymphoid neoplasms based on the NanoString platform. Zhang W; Ao Q; Guan Y; Zhu Z; Kuang D; Li MMQ; Shen K; Zhang M; Wang J; Yang L; Cai H; Wang Y; Young KH; Zhou J; Xiao M Mod Pathol; 2022 May; 35(5):632-639. PubMed ID: 34802044 [TBL] [Abstract][Full Text] [Related]
16. [Nodal lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia: a clinicopathological and prognostical study]. Zhang DD; Hu PZ; Li P; Jiang GZ; Yin YH; Wang GN; Zhao WG; Zhang YP; Li WC Zhonghua Bing Li Xue Za Zhi; 2021 Jun; 50(6):592-597. PubMed ID: 34078045 [No Abstract] [Full Text] [Related]
17. Lymphoplasmacytic lymphoma and Waldenström macroglobulinaemia: clinicopathological features and differential diagnosis. Wang W; Lin P Pathology; 2020 Jan; 52(1):6-14. PubMed ID: 31767130 [TBL] [Abstract][Full Text] [Related]
18. MYD88 L265P mutation analysis is a useful diagnostic adjunct for lymphoplasmacytic lymphoma with pleural effusion. Pan ST; Wang RC; Kuo CC; Hsieh YC; Su YZ; Chuang SS Pathol Int; 2019 Oct; 69(10):601-607. PubMed ID: 31556196 [TBL] [Abstract][Full Text] [Related]
19. Detection of MYD88 L265P mutations in formalin-fixed and decalcified BM biopsies from patients with lymphoplasmacytic lymphoma. Capaldi IB; May AM; Schmitt-Graeff A; Follo M; Aumann K; Kayser G; Perazzo JC; Werner M; Fisch P Exp Mol Pathol; 2014 Aug; 97(1):57-65. PubMed ID: 24842316 [TBL] [Abstract][Full Text] [Related]
20. [Successful diagnosis of lymphoplasmacytic lymphoma with IgG paraprotein using MYD88 L265P mutation analysis]. Abe M; Saburi M; Itani K; Kohno K; Soga Y; Kondo Y; Kawano Y; Nakayama T Rinsho Ketsueki; 2018; 59(6):695-697. PubMed ID: 29973445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]